VG Life Sciences Competitors and Similar CompaniesClear all
Epizyme's competitors and similar companies include Outlook Therapeutics.
 Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Outlook Therapeutics Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. | |
Founding Date | Founding Date 2007 | Founding Date 2011 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Woodbridge Township, US HQ |
Employees | Employees 20364% increase | Employees 1726% decrease |
Valuation ($) | Valuation ($) 250.8 m | Valuation ($) 136.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) $1.4m (FY, 2025) |
Cost of goods | Cost of goods $10.5m (FY, 2021) | Cost of goods $1.4m (FY, 2025) |
Net income | Net income ($251.1m) (FY, 2021) | Net income ($62.4m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Outlook Therapeutics
HQ
Woodbridge Township, US
Employees
17↓ 26% decrease
Outlook Therapeutics (formerly Oncobiologics) is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics.
View company